Why investors should look at the looming 'lumber super cycle'

ON TIMBER

clock

The revival in the US housing market will mean good things for America's favourite housebuilding material: timber, said Pictet fund managers Christoph Butz and Gabriel Micheli.

Investors seeking to capitalise on some of the most powerful economic and demographic forces shaping our world would do well to look at timber. There are numerous companies operating along the timber value chain that present an attractive investment proposition, and they do so for a number of reasons. Chief among these is the US housing market, the main source of timber demand worldwide. Indeed, this is the ultimate destination of some 70% of the trees harvested in the US. And this is not likely to change any time soon for the US remains severely underbuilt. Last year, only 780,000...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot